Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2021-07-02 00:00:00 ET · period of report 2021-06-30 · accession 0000899243-21-027313 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-02 | 2021-06-30 | BEAM | Burrell Terry-Ann | CFO | S - Sale+OE | $122.00 | -30.0K | 39.8K | -43% | -$3.66M |
| D | 2021-07-02 | 2021-06-30 | BEAM | Burrell Terry-Ann | CFO | M - OptEx | $13.68 | +30.0K | 54.8K | +121% | +$410.4K |
| D | 2021-07-02 | 2021-06-30 | BEAM | Burrell Terry-Ann | CFO | M - OptEx | $0.00 | -30.0K | 282.9K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-30 | S | D | 15,000 | $127.00 | 24,809 | D | — | — | |
| 2 | Common | Common Stock | 2021-06-30 | S | D | 15,000 | $117.00 | 39,809 | D | — | — | |
| 3 | Common | Common Stock | 2021-06-30 | M | A | 30,000 | $13.68 | 54,809 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-06-30 | M | D | 30,000 | $0.00 | 282,941 | D | $13.68 · — to 2029-08-31 | 30,000 Common Stock | (F3) The option vests as to 25% on the first anniversary of the of the vesting commencement date, August 20, 2019, and at a rate of 2.78% each month thereafter until the option is fully vested. |